An upside to the European PIP breast implant scandal?

breast implants

Far from chilling the breast aesthetics market, the widespread breast implant recall in Europe may have an upside for device makers as patients opt to replace their potentially rupture-prone implants.

When French breast modification company Poly Implant Prosthèse was caught filling its breast implants with substandard silicone, rival implant makers took pains to distance themselves from the scandal for fear of being tangled in a PR nightmare.

Both Allergan (NYSE:AGN) and Johnson & Johnson (NYSE:JNJ) subsidiary Mentor Worldwide issued statements ensuring doctors and patients that their products were not part of the investigation and that the companies have no affiliation with PIP.

"Silicone gel-filled breast implants are among the most studied medical devices in existence, with more than 3,000 peer-reviewed and published reports on studies, including robust epidemiological studies, supporting their safe use," according to a December 2011 Allergan press release. "Gel-filled breast implants are safe and effective when used as intended."

News of the recall and the subsequent uproar led to criminal investigations, clinical studies and, apparently, a slew of revision surgeries. By the time the news made it to the U.S. late last year, surgeons had already explanted 523 PIP breast implants and 2,000 woman had filed complaints.

Those revision surgeries may have had a part to play in Allergan’s recent breast aesthetics sales spike, chairman, president & CEO David Pyott told investors during a conference call this week.

The company’s breast devices revenues jumped 17% in the 3 months ended March 31, with "particularly strong performance" in Europe and Latin America, Pyott said.

"Allergan implants have been chosen for revision surgery in the wake of the PIP scandal, which had its greatest impact in France and the U.K.," he told investors.

The company benefited from shift to higher-quality breast implant makers for 1st-time augmentation surgery patients as well.

"Given that we are by far the market leader in breast implants in Europe, we benefited, sadly, from patients where revision surgery had to be conducted," Pyott said. "A PIP implant was explanted and a new one was put in. But I think that only explains part of it. I think the second part is that plastic surgeons making their choice had a real move to the quality makers. And, of course, one of the biggest stamps of quality in the European market is who is approved in the United States."

At the time of the scandal only Mentor and Allergan had won FDA permission to sell breast implants in the U.S.

Santa Barbara, Calif.-based became the 3rd, over consumer group protests, when it landed FDA approval in March.

Calls to Mentor and Allergan were not returned.

RSS From Medical Design & Outsourcing

  • 3-phase current transducer from PEM delivers all-in-one convenience
    The new RCTrms 3-ph current transducer from Power Electronic Measurements (PEM) delivers a convenient, safe and accurate solution for measuring current in three phases. It features a thin, clip-around, flexible sensor coil and provides accurate true rms measurement with 4-20 mA or 0-5 V output, enabling simple installation with PLC’s, SCADA systems or automation equipment. […]
  • Safety alert: Recall on two IV solutions from Baxter
    Baxter International announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital and user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to […]
  • TSO3 begins shipment of STERIZONE VP4 Sterilizers to U.S.
    TSO3, a developer in sterilization technology for medical devices in healthcare settings, announced that the company has received purchase orders for multiple devices from the U.S. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and TSO3. “Finally,” said R.M. Rumble, president and CEO of TSO3. “Our Vision is […]
  • Turkish medical company is seeking reseller and OEM partners in the U.S.
    UZUMCU Medical Equipment, one of Turkey’s first and largest manufacturers of medical devices, is seeking reseller and OEM partners in the U.S. The company has an array of FDA-certified OR tables, surgical lights, surgical suction units, electro devices and other medical equipment. “We want to bring our experience with distributors throughout Europe and the Middle […]
  • QImaging introduces new CCD cameras for microscopy with modern software to streamline image capture
    QImaging, a manufacturer of scientific cameras for life science and OEM applications, introduces a new series of Retiga CCD cameras, accompanied by QImaging’s new acquisition software to deliver high-performance tools for microscopy and imaging to researchers at an affordable price. The new QImaging Retiga R1, Retiga R3 and Retiga R6 cameras offer valuable technical features […]
  • Sigma-Aldrich announces a new certification to aid IVD customers
    Sigma-Aldrich, a life science and high technology company, announced the company has received ISO 13485 certification for expanded quality assurance capabilities at its Dekalb and Barton facilities located in St. Louis. The certification extends Sigma-Aldrich’s ability to manufacture and offer critical raw materials, such as enzymes, proteins and antibodies used in diagnostic assays, and supplies in vitro […]
  • Prescribing the right power supply: Important considerations for using batteries to power medical devices
    Sol Jacobs, VP and General Manager, Tadiran Batteries Medical technology is advancing rapidly, requiring increasingly sophisticated power management solutions, especially when then the device needs to be self-powered. Battery-powered medical devices encompass a wide range of applications, including surgical drills, power tools, automatic external defibrillators (AEDs), infusion pumps, bone growth stimulators and other wearable devices, […]
  • Qosina announces the launch of its e-commerce website
    Qosina is pleased to announce the launch of its e-commerce website, making it easier to purchase thousands of medical device components from stock inventory. Visitors coming to the new Qosina.com will discover a new look and feel and improvements with every click including: · Easy navigation: A new category structure that mirrors the print catalog […]
  • Athermal laser machining for medical implants is the topic of Norman Noble’s latest whitepaper
    Thermal lasers have achieved extraordinary results in microprecision manufacturing of medical implants and devices the past 20 years. Devices we take for granted today, such as vascular stents, could not be produced without the technology; however, there are still significant limitations on what medical implant and device manufactures can produce using thermal lasers. One major issue […]
  • Sealevel announces the SeaISO family of USB isolators
    Sealevel announces the SeaISO family of USB isolators with 4 kV of medical-grade optical isolation between the host computer and connected USB equipment. SeaISO USB isolators are UL Recognized, in accordance with EN60601-1 3rd Edition, and protect both the power and data lines of connected USB devices from harmful ground loops, damaging transients and surges […]
  • The 21st Century Cures Discussion document recently released to the public
    It has been reported that among the 10,000 known diseases, 7,000 of which are considered rare, there are treatments for only 500. According to Dr. Francis Collins, Director of the National Institutes of Health (NIH), it now takes “around 14 years and $2 billion or more” to develop a new drug and “more than 95% […]

Leave a Reply